Table 3.
Hormonal profile of participants.
| CZP | LTC | p-VALUE | |
|---|---|---|---|
| Follicular Phase, Median (IQR) | |||
| FSH (mIU/ml) | 5.8 (3.3–12.0) | 5.5 (3.7–6.5) | 0.554 |
| LH (mIU/ml) | 6.5 (4.4–15.5) | 6.3 (4.3–8.7) | 0.560 |
| Progesterone (ng/ml) | 0.8 (0.4–4.2) | 1.5 (0.9–10.0) | 0.056 |
| Estradiol (pg/ml) | 68.9 (44.6–110.7) | 85.2 (68.9–169.0) | 0.061 |
| Luteal Phase, Median (IQR) | |||
| FSH (mIU/ml) | 5.6 (2.8–10.4) | 5.6 (3.7–6.5) | 0.766 |
| LH (mIU/ml) | 7.4 (4.5–16.3) | 5.0 (3.6–6.5) | 0.006* |
| Progesterone (ng/ml) | 0.8 (0.6–4.1) | 1.5 (0.7–17.6) | 0.142 |
| Estradiol (pg/ml) | 71.5 (46.1–128.5) | 80.0 (53.7–144.9) | 0.540 |
| TESTOSTERONE (nmol/L) | 1.0 (0.8–1.8) | 1.8 (1.2–2.3) | 0.004* |
CZP – Carbamazepine, LTC – Levetiracetam, FSH – Follicle Stimulating Hormone, LH – Luteinizing Hormone, IQR – Inter-Quartile Range, *Statistically significance.